SEC Company Response from Lexaria Bioscience (LEXX) — Dec 5, 2025
Lexaria Bioscience Corp.
Date: Dec. 5, 2025 · CIK: 0001348362 · Accession: 0001640334-25-002257
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290862
Letter
lxrp_corresp.htm December 5, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Lexaria Bioscience Corp. (the “Company”) Registration Statement on Form S-1 (the “Registration Statement”) File No. 333-290862 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time on December 9, 2025, or as soon thereafter as is practicable. If you have any questions, please call Avital Perlman, Esq. at (212) 930-9700. Very truly yours, LEXARIA BIOSCIENCE CORP. By: /s/ Richard Christopher Name: Richard Christopher Title: Chief Executive Officer
Show Raw Text
CORRESP 1 filename1.htm lxrp_corresp.htm December 5, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Lexaria Bioscience Corp. (the “Company”) Registration Statement on Form S-1 (the “Registration Statement”) File No. 333-290862 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time on December 9, 2025, or as soon thereafter as is practicable. If you have any questions, please call Avital Perlman, Esq. at (212) 930-9700. Very truly yours, LEXARIA BIOSCIENCE CORP. By: /s/ Richard Christopher Name: Richard Christopher Title: Chief Executive Officer